Triglimibrit 2mg/500mg/0.2mg Tablet
Marketer
Elbrit Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triglimibrit 2mg/500mg/0.2mg Tablet
DiaBetaCombo 2mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This formulation helps manage blood glucose. DiaBetaCombo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and how to treat them. Regular meals and readily available glucose sources (sugary foods or juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling (edema), blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before initiating treatment. Consult your physician before using this medication during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) may be recommended.
Primary Ingredients of Triglimibrit 2mg/500mg/0.2mg Tablet
No text provided. Please provide the text you would like me to rephrase.
Uses of Triglimibrit 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Triglimibrit 2mg/500mg/0.2mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the Triglimibrit 2mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer on an empty stomach.
Common Side effects of Triglimibrit 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triglimibrit 2mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Triglimibrit 2mg/500mg/0.2mg Tablet whole; do not bite, pulverize, or fracture it. Administer on an empty stomach.
How Triglimibrit 2mg/500mg/0.2mg Tablet works:
Each Triglimibrit 2mg/500mg/0.2mg tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Triglimibrit 2mg/500mg/0.2mg tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
Use of Triglimibrit 2mg/500mg/0.2mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimibrit 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Triglimibrit 2mg/500mg/0.2mg tablets in individuals with kidney impairment carries a high risk and is best avoided. Medical advice is essential. Furthermore, its use is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Triglimibrit 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised. For those with mild to moderate liver disease, initiate treatment with a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Triglimibrit 2mg/500mg/0.2mg Tablet :
Should you forget to take your Triglimibrit 2mg/500mg/0.2mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimibrit 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently